Biologic tezepelumab shows positive results in severe, uncontrolled asthma
Tezepelumab is associated with reduced exacerbations, hospitalizations and ER visits in people with severe, uncontrolled asthma. It may also challenge the current step of biomarker assessment before initiating treatment with a biologic.